---
figid: PMC7188351__kchl-14-01-1750189-g006
figtitle: Schematic of the hypothesis that CaMKII-induced CaV1.2 channel phosphorylation
  at the Thr1604 site induces pathological myocardial hypertrophy development in rats
organisms:
- Mus musculus
- Rattus norvegicus
- Cavia porcellus
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7188351
filename: kchl-14-01-1750189-g006.jpg
figlink: pmc/articles/PMC7188351/figure/F0006/
number: F6
caption: 'A schematic of the hypothesis that CaMKII-induced CaV1.2 channel phosphorylation
  at the Thr1604 site induces pathological myocardial hypertrophy development in rats.
  Briefly, a signaling cascade after ISO-dependent stimulation of cardiomyocyte β-ARs
  involves the activation of Gs proteins, which in turn stimulate cyclic adenosine
  monophosphate (cAMP). Exchange protein directly activated by cAMP (Epac) activates
  CaMKII-mediated phosphorylation of CaV1.2 at the C-terminal Thr1604 site, opening
  the CaV1.2 channel and increasing intracellular calcium levels. The latter further
  promotes CaMKII autophosphorylation. This positive feedback mechanism enhances the
  CaMKII/HDAC/ANP hypertrophic signaling pathway. Moreover, elevated intracellular
  calcium may also act on the β-AR/PKA hypertrophic signaling pathway, as reported
  by the group of William A. Catterall [,,], eventually leading to irreversible cardiac
  hypertrophy and heart failure. β-AR: β-adrenergic receptor; cAMP: cyclic adenosine
  monophosphate; Epac: exchange protein directly activated by cAMP; CaMKII: Ca2+/calmodulin-dependent
  protein kinase II; HDAC: histone deacetylase; PKA: protein kinase A; CaN: calcineurin;
  NFAT: nuclear factor of activated T cells; ANP: atrial natriuretic peptide; BNP:
  B-type natriuretic peptide; and β-MHC: β-myosin heavy chain.'
papertitle: The CaMKII phosphorylation site Thr1604 in the CaV1.2 channel is involved
  in pathological myocardial hypertrophy in rats.
reftext: Jingyuan Li, et al. Channels (Austin). 2020;14(1):151-162.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9595012
figid_alias: PMC7188351__F6
figtype: Figure
redirect_from: /figures/PMC7188351__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7188351__kchl-14-01-1750189-g006.html
  '@type': Dataset
  description: 'A schematic of the hypothesis that CaMKII-induced CaV1.2 channel phosphorylation
    at the Thr1604 site induces pathological myocardial hypertrophy development in
    rats. Briefly, a signaling cascade after ISO-dependent stimulation of cardiomyocyte
    β-ARs involves the activation of Gs proteins, which in turn stimulate cyclic adenosine
    monophosphate (cAMP). Exchange protein directly activated by cAMP (Epac) activates
    CaMKII-mediated phosphorylation of CaV1.2 at the C-terminal Thr1604 site, opening
    the CaV1.2 channel and increasing intracellular calcium levels. The latter further
    promotes CaMKII autophosphorylation. This positive feedback mechanism enhances
    the CaMKII/HDAC/ANP hypertrophic signaling pathway. Moreover, elevated intracellular
    calcium may also act on the β-AR/PKA hypertrophic signaling pathway, as reported
    by the group of William A. Catterall [,,], eventually leading to irreversible
    cardiac hypertrophy and heart failure. β-AR: β-adrenergic receptor; cAMP: cyclic
    adenosine monophosphate; Epac: exchange protein directly activated by cAMP; CaMKII:
    Ca2+/calmodulin-dependent protein kinase II; HDAC: histone deacetylase; PKA: protein
    kinase A; CaN: calcineurin; NFAT: nuclear factor of activated T cells; ANP: atrial
    natriuretic peptide; BNP: B-type natriuretic peptide; and β-MHC: β-myosin heavy
    chain.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cacna1c
  - Adrb1
  - ac
  - Camk2a
  - Camk2b
  - Mef2c
  - Myef2l
  - Nppb
  - Myh7
  - Nppa
  - Myh6
  - CACNA1C
  - ADRB2
  - NR1H4
  - BFAR
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CAMK2G
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - MEF2A
  - MYEF2
  - MEF2C
  - MEF2D
  - MEF2B
  - NPPB
  - NPPA
  - MYH6
  - B-H2
  - B-H1
  - hh
  - .na.character
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - CaMKII
  - NFAT
  - Mef2
  - Anp
  - Ca2+
  - CaN
---
